2 transcripts
JAZZ
Earnings call transcript
NASDAQ
2024 Q2
31 Jul 24
in healthy volunteers, and we've been able to assess the dose response characteristics in the healthy volunteer sleep deprivation model. We know from the field
JAZZ
Earnings call transcript
NASDAQ
2023 Q2
9 Aug 23
proof of concept in healthy volunteers later this year. In addition, we have ongoing trials for suvecaltamide in both essential tremor or ET
- Prev
- 1
- Next